Invasive breast cancer (IBC) can be classified into different gene expression-based subtypes, namely Luminal A, Luminal B, HER2-enriched, and basal-like, which are associated with different prognosis and different response to therapy [1,2,3]. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.